4//SEC Filing
KINGSLEY ALFRED D 4
Accession 0001493152-21-015072
CIK 0000876343other
Filed
Jun 22, 8:00 PM ET
Accepted
Jun 23, 1:15 PM ET
Size
19.4 KB
Accession
0001493152-21-015072
Insider Transaction Report
Form 4
KINGSLEY ALFRED D
10% Owner
Transactions
- Exercise/Conversion
Common Shares, no par value
2021-06-22$2.20/sh+61,800$135,960→ 5,470,245 total - Exercise/Conversion
Stock Option (right to buy)
2021-06-22−61,800→ 0 totalExercise: $2.20Exp: 2021-06-30→ Common Shares (61,800 underlying)
Holdings
- 1,043,346(indirect: By corporation)
Common Shares, no par value
- 375,351(indirect: By LP)
Common Shares, no par value
Footnotes (3)
- [F1]Held by Greenbelt Corporation, of which Mr. Kingsley is an executive officer, director, and controlling shareholder. Mr. Kingsley disclaims beneficial ownership of these shares, except to the extent of his pecuniary interest.
- [F2]Held by Greenway Partners, LP, of which Mr. Kingsley is the General Partner and has sole voting and dispositive control.
- [F3]This option became exercisable in four equal quarterly installments after the date of grant on July 1, 2016.
Documents
Issuer
Lineage Cell Therapeutics, Inc.
CIK 0000876343
Entity typeother
Related Parties
1- filerCIK 0001229339
Filing Metadata
- Form type
- 4
- Filed
- Jun 22, 8:00 PM ET
- Accepted
- Jun 23, 1:15 PM ET
- Size
- 19.4 KB